INmune Bio Inc

NASDAQ:INMB   11:42:47 AM EDT
11.49
-0.14 (-1.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)207.08M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.04 Million
Adjusted EPS-$0.43
See more estimates
10-Day MA$11.69
50-Day MA$12.07
200-Day MA$9.52
See more pivots

INmune Bio Inc Stock, NASDAQ:INMB

225 NE Mizner Boulevard, Suite 640, Boca Raton, Florida 33432
United States of America
Phone: +1.858.964.3720
Number of Employees: 10

Description

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer�s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.